# Bacta

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bacta

- Industry: Biotechnology
- Headquarters: Paris, France
- Website: www.bacta.bio/
- Total disclosed funding: $8.2M
- Latest round: Seed (Feb 9, 2026)
- Investors on record: 3

## About

Founded in 2024 and based in Paris, France, Lastix Biotech SAS, trading under the name Bacta, operates as a biotechnology research company that develops and produces biosynthetic carbon-negative natural rubber from engineered microorganisms and renewable feedstocks. The company was founded by its CEO, Mathieu Nohet. In October 2024, Bacta raised EUR 3.3 million in pre-seed funding led by Ovni Capital, including Kima Ventures, Sharpstone Capital, and another.vc.

The company specializes in the development of carbon-negative, biosynthetic natural rubber using advanced bioengineering. Bacta's approach employs a mixotrophic process where microorganisms capture CO2 and other renewable carbon sources to synthesize isoprene. The process involves fermentation with AI-designed enzymes, polymerization through proprietary synthetic organelles, and purification to deliver hypoallergenic rubber with ultra-low impurity levels. This method is carbon-neutral and has a carbon-negative impact of up to -151%, making it a sustainable alternative. Bacta combines AI-driven discovery with synthetic biology, achieving a consistent product through its platform.

The organization plans to use the October 2024 funding to hire additional scientists and scale up its production capabilities.

## Funding rounds

- Seed, Feb 9, 2026, $8.2M — LocalGlobe, Daphni, Ovni Capital

## Investors

- LocalGlobe (https://capitalatlas.ai/funds/localglobe) — Seed
- Daphni (https://capitalatlas.ai/funds/daphni) — Seed
- Ovni Capital (https://capitalatlas.ai/funds/ovni-capital) — Seed